A randomized, double-blind, placebo-controlled, parallel-group, multicenter Phase 3 study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with non-diabetic chronic ...
Lay Description
Category
- Urinary Tract and Kidney
- IRB Number
- 20210618HU
- NCT Number
- NCT # not yet entered
Eligibility
- Eligible Ages
- Eligible Genders
- Accepts Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups
Study Contact
Jonathan Polanco
210-450-9097
polancoj@uthscsa.edu
Principal Investigator
Shweta Bansal